The management of necrosis-associated and idiopathic bone-marrow oedema of the proximal femur by intravenous iloprost

Journal of Bone and Joint Surgery - Series B

Volumn 87, Issue 4, 2005, Pages 560-564

  Disch, Alexander C ^a   Matziolis, G ^a   Perka, C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ILOPROST;

ADULT; ARTHRALGIA; ARTICLE; BONE MARROW DISEASE; BONE NECROSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; EDEMA; ERYTHEMA; FEMALE; FLUSHING; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; INJECTION SITE REACTION; JOINT CHARACTERISTICS AND FUNCTIONS; MALE; MYALGIA; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SATISFACTION; PRIORITY JOURNAL; SCORING SYSTEM; SIDE EFFECT; SKIN MANIFESTATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VISUAL ANALOG SCALE;

ADULT; AGED; BONE MARROW DISEASES; CASE-CONTROL STUDIES; EDEMA; FEMALE; FEMUR HEAD NECROSIS; HIP JOINT; HUMANS; ILOPROST; INFUSIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PAIN MEASUREMENT; RANGE OF MOTION, ARTICULAR; RISK FACTORS; SINGLE-BLIND METHOD; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 17744387748     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.87B4.15658     Document Type: Article

References (51)

1. Beltran J, Shankman S. Magnetic resonance imaging of bone marrow disorders of the knee. Magn Reson Imaging Clin N Am 1994;2:463-73.
2. Calvo E, Alvarez L, Fernandez-Yruegas D, Vallejo C. Transient osteoporosis of the foot: bone marrow edema in 4 cases studied with MRI. Acta Orthop Scand 1997;68:577-80.
3. Andrews CL. Radiological society of north America: evaluation of the marrow space in the adult hip. Radiographics 2000;20:27-42.
4. Hayes CW, Conway WF, Daniel WW. MR imaging of bone marrow oedema pattern: transient osteoporosis, transient bone marrow edema syndrome, or osteonecrosis. Radiographics 1993;13:1001-11.
5. Bollet AJ. Edema of the bone marrow can cause pain in osteoarthritis and other diseases of bone and joints. Ann Intern Med 2001;134:591-3.
6. Felson DT, Chaisson CE, Hill CL, et al. The association of bone marrow lesions with pain in knee osteoarthritis. Ann Intern Med 2001;134:541-9.
7. Koo KH, Ahn IO, Kim R, et al. Bone marrow edema and associated pain in early stage osteonecrosis of the femoral head: prospective study with serial MR images. Radiology 1999; 213:715-22.
8. Hofmann S. Bone-marrow edema in transient osteoporosis, reflect sympathetic dystrophy and osteonecrosis. In: Jacob RP, Fulford P, Horan F, eds. European Instructional Course Lectures. Vol. 4. London: The British Editorial Society of Bone and Joint Surgery 1999:138-51.
9. Hofmann S, Engel A, Neuhold A, et al. Bone-marrow oedema syndrome and transient osteoporosis of the hip: an MRI-controlled study of treatment by core decompression. J Bone Joint Surg [Br] l993;75-B:210-16.
10. Hofmann S, Kramer J, Leder K, Plenk H Jr, Engel A. The non-traumatic femur head necrosis in the adult. I: pathophysiology, clinical picture and therapeutic options. Radiologe 1994;34:1-10 (in German).
11. Plenk H Jr, Hofmann S, Eschberger J, et al. Histomorphology and bone morphometry of the bone marrow edema syndrome of the hip. Clin Orthop 1997;334:73-84.
12. Doury P. Bone-marrow oedema, transient osteoporosis, and algodystrophy. J Bone Joint Surg [Br] 1994;76-B:993-4.
13. Grant SM, Goa KL. Iloprost: a review of its pharmacodynamic and pharmcokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischemia and extracorporal circulation procedures. Drugs 1992;43:889-924.
14. Aigner N, Petje G, Schneider W, et al. Juvenile bone-marrow oedema of the acetabulum treated by iloprost. J Bone Joint Surg [Br] 2002;84-B:1050-2.
15. Aigner N, Petje G, Steinboeck G, et al. Treatment of bone-marrow edema of the talus with the prostacyclin analogue iloprost: an MRI-controlled investigation of a new method. J Bone Joint Surg [Br] 2001;83-B:855-8.
16. Aigner N, Petje G, Steinboeck G, et al. Bone marrow edema of the forefoot after chevron osteotomy: a rare cause of metatarsalgia. Foot Ankle Int 2002;23:447-51.
17. Petje G, Radler C, Aigner N, et al. Aseptic bone necrosis in childhood: diagnosis and treatment. Orthopäde 2002;31:1027-38 (in German).
18. Kramer J, Breitenseher M, Imhof H, et al. Diagnostic imaging in femur head necrosis. Orthopäde 2000;29:380-8 (in German).
19. Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. J Bone Joint Surg [Am] 1969;51-A:737-55.
20. Arlet J, Ficat P. Transosseous phlebography, intramedullary pressure and osseous blood oximetry in sympathetic reflex algodystrophies. Rev Rhum Mal Osteoartic 1982;49:883-8 (in French).
21. Arlet J, Ficat P, Durrow R, et al. Histopathology of bone lesions in 9 cases of algodystrophy of the hip. Rev Rhum Mal Osteoartic 1978;45:691-8 (in French).
22. Arlet J, Ficat P, Sebbag D. The use of measurement of intramedullary pressure in the greater trochanter in man, particularly in the diagnosis of osteonecrosis of the femoral head. Rev Rhum Mal Osteoartic 1968;35:250-6 (in French).
23. Tsuji T, Sugano N, Sakai T, et al. Evaluation of femoral perfusion in a non-traumatic rabbit osteonecrosis model with T2*-weighted dynamic MRI. J Orthop Res 2003;21:341-51.
24. Lundgaard A, Aalkjaer C, Holm-Nielsen P, Mulvany MJ, Hanssen ES. Method for assessment of vascular reactivity in bone: in vitro studies on resistance arteries isolated from porcine cancellous bone. J Orthop Res 1996;14:962-71.
25. Uchio Y, Ochi M, Adachi N, Nishikori T, Kawasaki K. Introsseous hypertension and venous congestion in osteonecrosis of the knee. Clin Orthop 2001;384:217-23.
26. Lundgaard A, Aalkjaer C, Bjurholm A, Mulvany MJ, Hansen ES. Vasorelaxation in isolated bone arteries: vasoactive intestinal peptide, substance P, calcitonin gene-related peptide, and bradykinin studied in pigs. Acta Orthop Scand 1997;68:481-9.
27. Brinker MR, Lippton HL, Cook SD, Hyman AL. Pharmacological regulation of the circulation of bone. J Bone Joint Surg [Am] 1990;72-A:964-75.
28. Schneider T, Drescher W, Becker C, et al. The impact of vasoactive substances on intraosseous pressure and blood flow alterations in the femoral head: a study based on magnetic resonance imaging. Arch Orthop Trauma Surg 1998;118:45-9.
29. Schneider T, Drescher W, Becker C, et al. Effect of bradykinin on pressure changes in the femur head epiphysis: an experimental and magnetic resonance tomography study. Z Orthop Ihre Grenzgeb 1998;136:439-43 (in German).
30. Bjurholm A. Neuroendocrine peptides in bone. Int Orthop 1991;15:325-9.
31. Berger CE, Kluger R, Urban M, et al. Elevated levels of lipoprotein(a) in familial bone marrow edema syndrome of the hip. Clin Orthop 2000; 377:126-31.
32. Arlet J, Mazieres B, Thiechart M, Vallieres G. The effect of i.v. injection naftidrofuryl (praxilene) on the intramedullary pressure in patients with osteonecrosis of the femoral head. In: Arlet J, Mazieres B, eds. Bone circulation and bone necrosis. Berlin, etc: Springer, 1990:405-6.
33. Laroche M, Jaquermier JM, Montane de la Roque PH, et al. Nifedipine per os relieved the pain caused by osteonecrosis of the femur head. Rev Rhum Mal Osteoartic 1990;57:669-70 (in French).
34. Glueck CJ, Freiberg RA, Fontaine RN, Tracy T, Wang P. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop 2001;386:19-33.
35. Debey S, Meyer-Kirchrath J, Schror K. Regulation of cyclooxygenase-2 expression by iloprost in human vascular smooth muscle cells: role of transcription factors CREB and ICER. Biochem Pharmacol 2003;65:979-88.
36. Coste F, Merle d'Aubigné R, Postel M, et al. Course of primary osteonecrosis of the femoral head (PON) and therapeutic prospects. Presse Méd 1965;73:263-7 (in French).
37. Merle d'Aubigné R, Postel M, Mazabraud A, et al. Idiopathic necrosis of the femoral head in adults. J Bone Joint Surg [Br] 1965;47-B:612-33.
38. Ohozono K, Saito M, Sugano N, Takaoka K, Ono K. The fate of nontraumatic vascular necrosis of the femoral head: a radiologic classification to formulate prognosis. Clin Orthop 1992;277:73-8.
39. Romer U, Wettstein P. Results of the treatment of 81 Swiss patients with INFH. In: Zinn WM, ed. Idiopathic ischemic necrosis of the femoral head in adults. Stuttgart: Thieme, 1971:205-12.
40. Krause R, Glas K, Schulz A, Gradinger R. The transitory bone marrow edema syndrome of the hip. Z Orthop Ihre Grenzgeb 2002;140:286-96 (in German).
41. Hofmann S, Mazières B. Osteonecrosis: natural course and conservative therapy. Orthopäde 2000;29:403-10 (in German).
42. Wirtz DC, Zilkens KW, Adam G, Nietherd FU. MRI-controlled results of femoral head necrosis and transient bone marrow oedema following core decompression. Z Orthop Ihre Grenzgeb 1998;136:138-46 (in German).
43. Crespo E, Sala D, Crespo R, Silvestre A. Transient osteoporosis. Acta Orthop Belg 2001;67:330-7.
44. Froberg PK, Braunstein EM, Buckwalter KA. Osteonecrosis, transient osteoporosis, and transient bone marrow oedema: current concepts. Radiol Clin North Am 1996;34:273-91.
45. Hungerford DS. Role of core-decompression as treatment method for ischemic femur head necrosis. Orthopäde 1990;19:219-23 (in German).
46. Guerra JJ, Steinberg ME. Distinguishing transient osteoporosis from avascular necrosis of the hip. J Bone Joint Surg [Br] 1995;77-B:616-24.
47. Neuhold A, Hofmann S, Engel A, et al. Bone marrow edema of the hip: MR findings after core decompression. J Comput Assist Tomogr 1992;16:951-5.
48. Specchiulli F. Core decompression in the treatment of necrosis of the femoral head: long-term results. Chir Organi Mov 2000;85:395-402.
49. Ficat RP. Idopathic bone necrosis of the femoral head. J Bone Joint Surg [Br] 1985;67-B:3-10.
50. Iida S, Harada Y, Shimizu K, et al. Correlation between bone marrow edema and collapse of the femoral head in steroid-induced osteonecrosis. AJR 2000;174:735-43.
51. Aigner N, Schneider W, Eberl V, Knahr K. Core-decompression in early stages of femoral head osteonecrosis: an MRI-controlled study. Int Orthop 2002;26:31-5.